OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 24, 2016

Primary Completion Date

October 22, 2019

Study Completion Date

November 5, 2021

Conditions
Liver TransplantationLiver Preservation for Transplant
Interventions
DEVICE

OCS™ Liver System

OTHER

Control

Trial Locations (20)

10029

Mount Sinai, New York

10467

Montefiore Einstein Center for Transplantation, The Bronx

21205

Johns Hopkins, Baltimore

22903

University of Virginia, Charlottesville

23298

Virginia Commonwealth University, Richmond

30322

Emory, Atlanta

33606

Tampa General, Tampa

38104

Methodist University Hospital, Memphis

43210

Ohio State University Medical Center, Columbus

48202

Henry Ford Hospital, Detroit

55455

University of Minnesota, Minneapolis

68198

University of Nebraska Medical Center, Omaha

75390

University of Texas Southwest, Dallas

77030

Houston Methodist, Houston

78249

University of Texas San Antonio, San Antonio

92037

University of California San Diego, La Jolla

92121

Scripps, San Diego

94143

University of California San Francisco, San Francisco

98195

University of Washington, Seattle

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT02522871 - OCS Liver PROTECT Trial: Preserving and Assessing Donor Livers for Transplantation | Biotech Hunter | Biotech Hunter